Related Experiment Video
Updated: Aug 6, 2026
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
High throughput screening in drug discovery
1Experimental Therapeutics Programme, CNIO, Madrid, Spain. acarnero@cnio.es
Summary
Drug discovery faces high attrition rates, driving the need for efficient screening methods. Innovations in cell biology and in silico drug design aim to improve the predictability of clinical efficacy for new anticancer drugs.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Drug discovery is a complex process with a high attrition rate, where millions of compounds are screened to find one marketable anticancer drug.
- Current drug discovery protocols rely heavily on High Throughput Screening (HTS) for large-scale compound testing, leading to significant time and cost investments.
Purpose of the Study:
- To explore strategies for reducing the cost and time associated with drug discovery.
- To enhance the predictability of clinical efficacy for newly identified antitumoral compounds.
Main Methods:
- Investigating advancements in laboratory automation for High Throughput Screening (HTS).
- Exploring developments in large-scale cell biology techniques.
- Utilizing in silico (computational) methods for compound library design.
Main Results:
- HTS enables the testing of hundreds of thousands of compounds daily, but reducing the number of compounds screened without compromising success rates is desirable.
- New approaches in cell biology and in silico design offer data with higher predictability of clinical efficacy.
Conclusions:
- Optimizing drug discovery processes is crucial due to high attrition rates and costs.
- Integrating advanced cell biology and in silico design can improve the efficiency and success rate of identifying effective anticancer drugs.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...